News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
3,461 Results
Type
Article (29)
Press Release (3432)
Section
Business (1335)
Career Advice (2)
Deals (180)
Drug Development (631)
FDA (95)
Job Trends (268)
News (2105)
Policy (116)
Tag
Academia (3)
Accelerated approval (1)
Allergies (2)
Alliances (44)
Alzheimer's disease (33)
Antibody-drug conjugate (ADC) (10)
Approvals (122)
Artificial intelligence (4)
Autoimmune disease (7)
Best Places to Work (297)
Breast cancer (18)
Cancer (137)
Cardiovascular disease (12)
Career advice (1)
Cell therapy (1)
Cervical cancer (1)
Clinical research (728)
Collaboration (9)
Compensation (4)
COVID-19 (4)
C-suite (1)
Data (189)
Depression (1)
Dermatology (1)
Diabetes (2)
Diagnostics (24)
Drug discovery (2)
Drug pricing (1)
Duchenne muscular dystrophy (1)
Earnings (1606)
Events (376)
FDA (181)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (1)
Funding (6)
Gene editing (1)
Generative AI (1)
Gene therapy (4)
GLP-1 (9)
Government (9)
Guidances (29)
Healthcare (86)
IgA nephropathy (3)
Infectious disease (5)
Inflammatory bowel disease (2)
IPO (162)
IRA (1)
Job creations (1)
Job search strategy (1)
Kidney cancer (2)
Layoffs (2)
Legal (1)
Lung cancer (44)
Lymphoma (18)
Manufacturing (3)
MASH (5)
Medical device (57)
Medtech (57)
Mergers & acquisitions (27)
Metabolic disorders (9)
mRNA (1)
Multiple sclerosis (10)
NASH (1)
Neurodegenerative disease (2)
Neuroscience (56)
NextGen: Class of 2026 (9)
Non-profit (4)
Obesity (1)
Opinion (1)
Ovarian cancer (5)
Pain (1)
Pancreatic cancer (2)
Parkinson's disease (3)
Patents (1)
Patient recruitment (1)
Peanut (1)
People (10)
Phase 1 (110)
Phase 2 (222)
Phase 3 (434)
Pipeline (218)
Policy (1)
Postmarket research (27)
Preclinical (13)
Prostate cancer (5)
Radiopharmaceuticals (6)
Rare diseases (12)
Regulatory (178)
Reports (2)
Research institute (6)
Resumes & cover letters (1)
Rett syndrome (2)
RSV (1)
Schizophrenia (6)
Sponsored (1)
Startups (3)
Vaccines (6)
Weight loss (1)
Date
Today (2)
Last 7 days (5)
Last 30 days (27)
Last 365 days (414)
2026 (120)
2025 (424)
2024 (419)
2023 (423)
2022 (418)
2021 (481)
2020 (310)
2019 (202)
2018 (150)
2017 (116)
2016 (39)
2015 (73)
2014 (43)
2013 (25)
2012 (28)
2011 (23)
2010 (22)
Location
Asia (374)
Australia (15)
California (128)
Canada (31)
China (21)
Colorado (1)
Connecticut (6)
Delaware (21)
Europe (693)
Florida (14)
Georgia (2)
Illinois (16)
Indiana (22)
Japan (30)
Kansas (1)
Maryland (22)
Massachusetts (85)
Minnesota (11)
New Jersey (104)
New York (51)
North Carolina (18)
Northern California (88)
Ohio (5)
Pennsylvania (37)
South America (5)
Southern California (36)
Texas (23)
United States (571)
Utah (8)
Virginia (1)
Washington State (6)
3,461 Results for "%E2%80%9D%20target=".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Kallyope’s Phase 2b Study of Elismetrep, A Novel Approach for Treating Migraine, Presented at the American Academy of Neurology Annual Meeting
April 23, 2026
·
6 min read
Press Releases
Roche’s fenebrutinib significantly reduced relapses versus standard of care to approximately one every 17 years in RMS
April 22, 2026
·
10 min read
Press Releases
EUROBIO SCIENTIFIC : 2025 ANNUAL RESULTS
April 12, 2026
·
8 min read
Press Releases
Zymeworks Presents New Phase 1 Data for ZW191, a Folate Receptor Alpha-Targeting ADC at AACR Annual Meeting 2026
April 22, 2026
·
10 min read
Press Releases
Alzheon to Present Evidence of Neurovascular Protection from Trials with Oral Valiltramiprosate in APOE4/4 Alzheimer’s Patients Leading to Reduced Brain Edema and Microhemorrhage Risk at 2026 American Academy of Neurology Meeting in Chicago, Illinois
April 14, 2026
·
12 min read
Press Releases
20 Abstracts at AACR Highlight Scale, Innovation and Clinical Impact of Natera’s Oncology Platform
April 7, 2026
·
5 min read
Press Releases
Genentech’s Fenebrutinib Significantly Reduced Relapses Versus Standard of Care to Approximately One Every 17 Years in RMS
April 22, 2026
·
15 min read
Press Releases
Rapport Therapeutics Presents RAP-219 Focal Onset Seizure Phase 2a Follow-up Period Results Demonstrating Sustained Seizure Reduction at the 2026 American Academy of Neurology Annual Meeting
April 22, 2026
·
12 min read
Press Releases
[Ad hoc announcement pursuant to Art. 53 LR] Roche reports strong sales growth of +6% at constant exchange rates in the first quarter of 2026; -5% in CHF due to the significant appreciation of the Swiss franc
April 23, 2026
·
20 min read
Press Releases
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care
March 30, 2026
·
16 min read
1 of 347
Next
